Investment
Features
FeesSafety
Academy
More
Pluang+

Warner Bros Discovery and Paramount shares jump on advanced settlement talks over $110B merger

Market News
21 Sep 2026
Proactive Investors
View Source
Bullish
Warner Bros Discovery and Paramount shares jump on advanced settlement talks over $110B merger

Shares of Warner Bros Discovery and Paramount Skydance rose sharply as Paramount entered advanced settlement talks with California's Attorney General over its $110 billion acquisition of Warner Bros Discovery. The deal faces antitrust lawsuits from 12 states and the Writers Guild of America. A proposed settlement includes financial penalties if the combined company fails to release 30 films annually and potential forced sale of a Miramax stake. Opposition to the settlement has grown due to concerns over control of CNN and merger impacts. Paramount warns it may leave Hollywood if the dispute isn't resolved, adding pressure on regulators. The merger, approved by shareholders in April, remains under negotiation amid these legal challenges.

Warner Bros Discovery and Paramount Skydance shares are the story's subject. For readers following the media sector, here is Pluang's market snapshot as of Sep 21, 2026 22:02 WIB: Of 42 priced US media stocks, 29 rose and 13 fell. Notable gainers include SNAP at USD 5.76 (+3.97%), ANGI at USD 5.47 (+3.21%), and MANU at USD 20.32 (+3.20%).

More News

Boeing faces 737 MAX production delays but analysts see potential 32% stock upside.

Boeing faces 737 MAX production delays but analysts see potential 32% stock upside.

Boeing is experiencing ongoing production challenges with its 737 MAX aircraft, causing delays and a recent 3.7% stock drop. Jefferies lowered its price target to $265, still implying a 32% upside from current prices, reflecting cautious optimism. Ba...

Analyst Insights
Neutral
37 minutes ago
Alkermes' ALKS7290 shows strong early results in ADHD treatment, boosting stock by 2.3%.

Alkermes' ALKS7290 shows strong early results in ADHD treatment, boosting stock by 2.3%.

Alkermes plc's drug ALKS7290 demonstrated significant improvement in ADHD symptoms in a Phase 1b trial, with patients showing a 14- to 19-point gain on a 54-point scale within two weeks. This outperforms typical placebo effects, which range from 6 to...

Market News
Bullish
3 hours ago
BrandPilot AI to attend Marketecture Live 2026, focusing on AI and transparency in digital advertising.

BrandPilot AI to attend Marketecture Live 2026, focusing on AI and transparency in digital advertising.

BrandPilot AI announced its participation in Marketecture Live 2026 in Chicago, an event that gathers advertising, media, and technology professionals to discuss industry developments. The company aims to engage in discussions about artificial intell...

Market News
Neutral
4 hours ago
Meta shares jump 12% on strong early adoption of Muse AI assistant and higher price target

Meta shares jump 12% on strong early adoption of Muse AI assistant and higher price target

Meta Platforms shares surged 12% to $747.91 following early success of its new Muse AI assistant, which topped Apple's US App Store with over 730,000 downloads shortly after launch. Wells Fargo raised Meta's price target to $796, citing strong moment...

Market News
Bullish
4 hours ago
Ventas posts strong Q2 2026 growth, raises full-year guidance on senior housing strength.

Ventas posts strong Q2 2026 growth, raises full-year guidance on senior housing strength.

Ventas reported solid Q2 2026 results with 10% same-store cash NOI growth and 9% normalized FFO/share growth, driven by its dominant senior housing portfolio. Management raised its 2026 FFO/share guidance and acquisition targets, citing a strong bala...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App